Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study. Alzforum, 22 Jul 2022 Park JM, Park D, Kim HJ, Park JS. BMC Neurol. 2022 Jul 14;22(1):260. PubMed.